O’donogue et al.41 reviewed the current literature and described two plausible hypotheses where the role of APOE ɛ4 during aging either can be explained as pre-clinical AD pathology (‘prodromal hypothesis’) or direct genetic effects independent of subsequent development of AD (‘phenotypic hypothesis’). The gene discussed is APOE; the disease is Alzheimer disease.